Fertility preservation for young women with cancer
Fertility Preservation in Young Women With Cancer: an International Registration Study From the International Network on Cancer, Infertility and Pregnancy (INCIP)
University Hospital, Gasthuisberg · NCT02878434
This study looks at how well fertility-preserving treatments work for young women with cancer compared to standard cancer treatments to help them understand their options for having children later on.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 0 Years to 40 Years |
| Sex | Female |
| Sponsor | University Hospital, Gasthuisberg (other) |
| Locations | 2 sites (Leuven and 1 other locations) |
| Trial ID | NCT02878434 on ClinicalTrials.gov |
What this trial studies
This observational study aims to document the incidence and long-term outcomes of fertility-preserving treatments in young women diagnosed with cancer. It compares the fertility and oncological outcomes of patients receiving fertility-sparing treatments to those undergoing standard cancer therapies. The study is conducted internationally across multiple centers, focusing on improving the quality of life for young cancer patients by addressing their fertility concerns. By gathering comprehensive data, the study seeks to inform clinicians and patients about the efficacy and safety of these specialized treatment protocols.
Who should consider this trial
Good fit: Ideal candidates for this study are young women diagnosed with cancer who wish to preserve their fertility during treatment.
Not a fit: Patients who are mentally disabled or have significantly altered mental status that prevents them from giving informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide critical insights that enhance fertility preservation options for young women undergoing cancer treatment.
How similar studies have performed: Other studies have shown promising results in fertility preservation approaches, but this study aims to fill gaps in understanding the oncological safety of these methods.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Young women who want to preserve their fertility during cancer treatment. Patients need to give their signed and written informed consent to participate in the study. Exclusion Criteria: * Mentally disabled or significantly altered mental status that would prohibit the understanding and giving of informed consent
Where this trial is running
Leuven and 1 other locations
- UZ Gasthuisberg, Katholieke Universiteit Leuven — Leuven, Belgium (RECRUITING)
- The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital — Amsterdam, Netherlands (RECRUITING)
Study contacts
- Principal investigator: Frédéric Amant, MD, PhD — UZ Gasthuisberg & KU Leuven, Belgium
- Study coordinator: Katrien Van Tornout
- Email: katrien.vantornout@uzleuven.be
- Phone: +3216342876
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer, Fertility, Pregnancy, Chemotherapy, Radiotherapy, Long term, Follow up